Malaysia Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape

Malaysia Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape

Summary

GlobalData, the industry analysis specialist, has released its latest report: “Malaysia - Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Malaysia. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

The Malaysian pharmaceutical market is one of the major markets in the South-East Asian region and provides lucrative market for the foreign Medical Device. Demographic changes and high incidence of non-communicable diseases (NCDs) are expected to drive the healthcare market in the future. Malaysia's pharmaceutical market, based on production value, was worth $2.1 billion in 2016, which increased at a CAGR of 9.2% to 2.9 billion in 2020 in terms of US dollars. The market value is expected to grow further and is forecast to reach $5 billion by 2026 at a CAGR of 9.2%. The medical device market of Malaysia is expected to reach $2.2 billion in 2022 from 2017 at a CAGR of 11.4%. At a CAGR of 10.7%, it is further expected to reach $3.4B in 2026. In 2020, According to Malaysia External Trade Development Corporation (MATRADE), Malaysia’s export of medical devices saw double-digit growth valued at MYR30 billion ($7.2 billion). In November 2021, the Malaysia healthcare travel council (MHTC) announced its blueprint for medical tourism for 2021-25 to enhance and elevate the traveler experience, highlighting five areas of quality, affordability, safety, hospitality, and seamless journey. MHTC by 2025 expects to achieve a targeted $400 million value from healthcare. The Malaysian medical tourism market grew at a CAGR of 16.1% from $127M in 2011 to $362M in 2018. The growth rate is higher than the global average of 10-12% and the Asia-Pacific average of 12-14% over the same time-period.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Malaysia, and includes -

• An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers.
• Profiles and SWOT analyses of the major players in the pharmaceutical market: Roche, Novartis, GlaxoSmithKline (GSK), Pfizer, YSP SAH and Kotra pharma.
• Profiles and SWOT analyses of the major players in the medical device market: Abbott, Medtronic, GE Healthcare, Stryker, and LKL.
• An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices.
• Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure.
• An overview of the opportunities for and challenges to growth in the Malaysia’s healthcare market

Reasons to Buy

This report will enhance your decision-making capability by allowing you to -

• Develop business strategies by understanding the trends shaping and driving the Malaysia’s healthcare market
• Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact the Malaysia’s healthcare market in the future
• Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
• Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership